Analysis of CIS-regulation in synthetic and genomic enhancers

Active Grant Awarded

Award ID
R35GM161206
Recipient
Awarding agency
Obligated
$453,908

Award facts

Assistance listing
93.859 Biomedical Research and Research Training
Completion date 4% complete
Place of performance
St. Louis, MO 63110, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services National Institutes of Health National Institute of General Medical Sciences awarded The Washington University, through its Office of Sponsored Research Services, $453,908 on September 9, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to fund Grant R35GM161206, a research project on cis-regulation in synthetic and genomic enhancers. The recipient will identify and quantify three types of interactions within enhancers: cooperative and competitive interactions among binding sites for different transcription factors, interactions between enhancers and their chromatin environments, and interactions between enhancers and cell-type-specific trans environments. The stated goal is to improve models that predict how genetic variation affects gene expression, based on the project's hypothesis that current models lack predictive power because these interactions are poorly understood. The period of performance runs to an ultimate completion date of April 30, 2031, and work is performed in St. Louis, Missouri 63110. The assistance type is a grant.

Description

Abstract
A majority of heritable disease-causing variation resides in the non-coding portions of the genome. The leading hypothesis is that these variants perturb the functions of CIS-regulatory elements, such as enhancers. Our field has made strong progress identifying the DNA-binding specificities of the transcription factors that comprise enhancers. Based on these specificities, the field has also made strong progress identifying enhancers in the genome. However, we still lack robust models that predict the effects of sequence variations on enhancer activities. Our hypothesis is that this lack of predictive power stems from a lack of understanding of 1) the cooperative and competitive interactions within enhancers between sites for different transcription factors, 2) the interactions between enhancers and their chromatin environments, and 3) the interactions between enhancers and their cell-type specific trans environments. We aim to identify and quantify these types of interactions with the goal of improving models that predict the effects of genetic variation on gene expression.

Quick answers

Who received award R35GM161206?

R35GM161206 was awarded to The Washington University by National Institute of General Medical Sciences (National Institutes of Health) on September 9, 2026.

How much is award R35GM161206 worth?

$453,908 has been obligated on R35GM161206.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award